CARTHERA
CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders since.The company’s proprietary device called SonoCloud® is an intracranial ultrasound implant that temporarily opens the blood-brain barrier (BBB) and allows a significantly increased concentration of therapeutic molecules to reach the brain.
CARTHERA
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2010-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.carthera.eu
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
33.57 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Apache
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
European Innovation Council
European Innovation Council investment in Series C - CarThera
European Innovation Council
European Innovation Council investment in Grant - CarThera
Groupe Arnault
Groupe Arnault investment in Series B - CarThera
Supernova Invest
Supernova Invest investment in Series B - CarThera
Panakes Partners
Panakes Partners investment in Series B - CarThera
Sham Innovation Santé
Sham Innovation Santé investment in Series B - CarThera
AGORANOV
AGORANOV investment in Seed Round - CarThera
Official Site Inspections
http://www.carthera.eu Semrush global rank: 5.86 M Semrush visits lastest month: 1.41 K
- Host name: cluster030.hosting.ovh.net
- IP address: 145.239.37.162
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "CarThera"
About Us - Carthera
CarThera - Crunchbase Company Profile & Funding
Contact Email [email protected] CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders …See details»
CarThera - European Commission - European …
CarThera® designs and develops innovative medical devices using the therapeutic potential of ultrasound to significantly improve the efficacy, comfort, and cost of treating a range of medical conditions. CarThera® has focused on …See details»
Delivering anti-cancer drugs beyond the blood-brain barrier
Sep 6, 2024 Founded in 2010, CarThera is a clinical stage company that develops first-in-class medical devices using therapeutic ultrasounds to treat severe brain disorders (Glioblastoma, …See details»
Our News - Carthera
Carthera receives Orphan Drug Designation (ODD) from US and EU authorities for carboplatin in malignant glioma. 14 may 2024 - Orphan designation shows recognition of enhanced …See details»
Carthera 2025 Company Profile: Valuation, Funding & Investors
Relyens, Unorthodox Ventures, BOUSCAS, Saint-Genys, and European Innovation Council Fund are 5 of 15 investors who have invested in Carthera. Who are Carthera’s competitors? Saluda …See details»
Carthera wins U.S., EU orphan drug designation for SonoCloud
May 14, 2024 The designation allows Paris, France-based Carthera to use carboplatin chemotherapy in the treatment of malignant glioma. Carthera conducts this treatment through …See details»
CarThera - Org Chart, Teams, Culture & Jobs - The Org
View CarThera's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Company Profile: CarThera - Focused Ultrasound …
Apr 11, 2019 Tell us about CarThera’s company structure: ownership, lead executives, and their roles. The company was started with funding from the French government in 2010, and after, obtained several rounds of funding …See details»
Carthera - VentureRadar
Dec 11, 2016 Similar Companies: Cathera France Privately Held Carthera is a biotechnology firm specializing in the development of ultrasound-based medical devices for the treatment of …See details»
Carthera receives Orphan Drug Designation from US and EU …
May 14, 2024 Both offer unique opportunities for Carthera to extend its market exclusivity in the US and EU. Carthera is using carboplatin in the first registrational trial of its SonoCloud …See details»
Carthera company information, funding & investors | Observatoire ...
Carthera, a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Here you'll find information …See details»
Carthera brings Series B round to €42M with additional €4.5M fun
Carthera is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of brain disorders. ... www.carthera.eu Media and …See details»
CarThera to receive €2M grant and €10.5M equity from the …
Paris, France, September 14, 2020 – CarThera, a French company that designs and develops innovative ultrasound-based medical devices to treat brain disorders, today announces that it …See details»
CarThera Company Profile - Office Locations, Competitors ... - Craft
CarThera is a technology company which designs and develops therapeutic ultrasound-based medical devices for treating brain disorders. The Company's main product is SonoCloud, an …See details»
CarThera Company Information - Funding, Investors, and More
CarThera's technology offers potentially more effective solutions with fewer side effects, improving patient outcomes. Supported by investors like Unorthodox Ventures, CarThera appears poised …See details»
Carthera brings Series B round to €42M with additional €4.5M …
Dec 11, 2023 Carthera will use funds to launch first registrational trial in recurrent glioblastoma and expand pipeline in field of neurodegenerative diseases . Paris, ... www.carthera.eu. …See details»
CarThera to receive €2M grant and €10.5M equity from the …
Frederic Sottilini, CEO at CarThera. “The EIC grant will be a powerful financial tool for CarThera to keep apace in its developments and get to market quickly.” After successfully raising €10M …See details»
EU conference highlights cooperative contributions to industrial ...
1 day ago EU conference highlights cooperative contributions to industrial transformation . On March 18, 2025, the ILO participated in the European Commission conference on “Fostering …See details»
Future of European defence - European Commission
The ReArm Europe Plan/ Readiness 2030 will boost defence funding by giving EU countries more financial flexibility. It will achieve this by: activating the national escape clause of the Stability …See details»